Raymond E. Cabillot Sells 6,931 Shares of Pro-Dex, Inc. (NASDAQ:PDEX) Stock

Pro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot sold 6,931 shares of the stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $45.22, for a total value of $313,419.82. Following the completion of the transaction, the director now owns 337,752 shares of the company’s stock, valued at $15,273,145.44. The trade was a 2.01 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Pro-Dex Stock Performance

Shares of Pro-Dex stock opened at $41.65 on Thursday. The stock has a market cap of $135.78 million, a price-to-earnings ratio of 27.05 and a beta of 0.56. The company has a quick ratio of 1.94, a current ratio of 3.41 and a debt-to-equity ratio of 0.36. Pro-Dex, Inc. has a twelve month low of $16.18 and a twelve month high of $59.60. The company’s fifty day moving average is $48.09 and its 200 day moving average is $33.44.

Analysts Set New Price Targets

A number of brokerages have issued reports on PDEX. Ascendiant Capital Markets upped their target price on Pro-Dex from $30.00 to $52.00 and gave the stock a “buy” rating in a report on Monday, November 11th. StockNews.com upgraded shares of Pro-Dex from a “buy” rating to a “strong-buy” rating in a report on Saturday, December 14th.

Institutional Investors Weigh In On Pro-Dex

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Ritholtz Wealth Management bought a new stake in Pro-Dex in the fourth quarter valued at approximately $572,000. JPMorgan Chase & Co. lifted its position in shares of Pro-Dex by 2.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 24,790 shares of the medical instruments supplier’s stock worth $740,000 after purchasing an additional 529 shares during the period. Geode Capital Management LLC boosted its stake in shares of Pro-Dex by 9.1% in the 3rd quarter. Geode Capital Management LLC now owns 27,435 shares of the medical instruments supplier’s stock valued at $819,000 after purchasing an additional 2,296 shares during the last quarter. FMR LLC increased its position in shares of Pro-Dex by 34.9% during the third quarter. FMR LLC now owns 3,973 shares of the medical instruments supplier’s stock worth $119,000 after buying an additional 1,028 shares during the period. Finally, Bard Associates Inc. lifted its holdings in Pro-Dex by 17.6% in the third quarter. Bard Associates Inc. now owns 13,596 shares of the medical instruments supplier’s stock valued at $406,000 after buying an additional 2,031 shares during the period. Institutional investors and hedge funds own 15.28% of the company’s stock.

About Pro-Dex

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.